What question did this study set out to answer?

The aim is to investigate how TSZAF mc inhibits ovarian cancer through specific molecular pathways.

February 19, 2026Biological Procedures Online0 citationsOpen Access

TSZAF Monomer Combination Inhibits the Progression of Ovarian Cancer Via Regulating the AKT/FOXO3A-mediated Glycolysis Pathway

Key Points

The aim is to investigate how TSZAF mc inhibits ovarian cancer through specific molecular pathways.
Evaluation of TSZAF mc effects on ovarian cancer cells
Analysis of the AKT/FOXO3A glycolysis pathway regulation
Assessment of clinical efficacy indications
TSZAF mc significantly inhibits the progression of ovarian cancer.
The regulation of the AKT/FOXO3A-mediated glycolysis pathway was confirmed.
Findings suggest a potential therapeutic mechanism of TSZAF in ovarian cancer treatment.

Abstract

TSZAF mc inhibits ovarian cancer progression by regulating the AKT/ FOXO3A-mediated glycolysis pathway, which may represent one of the mechanisms underlying the clinical efficacy of TSZAF in ovarian cancer treatment.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Zhang et al. (Sat,) studied this question.

synapsesocial.com/papers/6996a82decb39a600b3ee978 https://doi.org/https://doi.org/10.1186/s12575-025-00323-z

AI से पूछें

Bookmark

View Full Paper